Status:
RECRUITING
Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborating Sponsors:
Johns Hopkins Bloomberg School of Public Health
Conditions:
Pedophilia
Hebephilia
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The goal of this patient preference randomized controlled trial is to investigate the efficacy of Talking for Change (TFC), an intervention for the secondary prevention of child sexual abuse and explo...
Detailed Description
Child sexual abuse (CSA) is a preventable public health issue that has significant mental health, physical health, financial, societal, and personal consequences. In Canada, perpetration prevention in...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- For the treatment arms, the participant must meet all of the inclusion criteria to eligible for this clinical trial:
- Must be deemed to have capacity to provide informed consent;
- Must sign and date the informed consent form;
- Stated willingness to comply with all study procedures;
- Be 18 years of age or older upon study commencement;
- Be referred for care in the TFC program due to concerns about enhanced risk of sexual offending against children.
- For the benchmarking interview arm, the participant must meet all of the following inclusion criteria:
- Must self-report concerns about enhanced risk of sexual offending against children
- Must be deemed to have capacity to provide informed consent;
- Must check the appropriate box on the informed consent form;
- Stated willingness to comply with all study procedures;
- Be 18 years of age or older upon study commencement.
- For the benchmarking survey arm, participants must check the appropriate box on the informed consent form.
- EXCLUSION CRITERIA:
- For the treatment arms:
- Inability to engage meaningfully in group psychotherapy (e.g., due to intellectual disability, other neurodiversity, active psychosis or substance use)
- Those who self-identify as at-risk for reasons better accounted for by non-risk-relevant factors per clinical assessment (e.g., those with obsessive-compulsive disorder including thoughts about CSA, who commonly fear that they are at-risk but are not).
- Non-male sex.
- For the benchmarking interview arm:
- 1\. Non-male sex.
Exclusion
Key Trial Info
Start Date :
April 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2026
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT07001735
Start Date
April 17 2025
End Date
December 15 2026
Last Update
June 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M6J 1H4